DexCom, Inc. (ETR:DC4)

Market Cap	21.99B
Revenue (ttm)	3.85B
Net Income (ttm)	614.25M
Shares Out	n/a
EPS (ttm)	1.53
PE Ratio	35.80
Forward PE	27.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	180
Open	56.39
Previous Close	56.33
Day's Range	56.39 - 56.39
52-Week Range	47.00 - 88.54
Beta	n/a
RSI	53.68
Earnings Date	Feb 13, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DC4

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD